Document is current

Article History

Received: 7 November 2024

Accepted: 16 December 2024

First Online: 6 January 2025

Declarations

:

: Miquel Bernardo has received grants and/or served as a consultant, advisor or speaker for AB-Biotics, Abartis Pharma, Adamed, Angelini Pharma, Casen Recordati, Esteve, Janssen-Cilag, Menarini, Rovi and Takeda. Marina Díaz Marsá has received grants and/or served as a consultant, advisor or speaker for Alter, Angelini, Idorsia, Janssen-Cilag, Lundbeck, Novartis, Otsuka, Rovi, Takeda, the Ministry of Science (Carlos III Institute), the Basque Government, and the European Framework Program of Research. Ana González-Pinto has received grants and/or served as a consultant, advisor or speaker for Janssen-Cilag, Lundbeck, Otsuka, Alter, Angelini, Novartis, Rovi, Takeda, Servier, the Spanish Ministry of Science and Innovation (CIBERSAM), the Ministry of Science (Carlos III Institute), the Basque Government, and the European Framework Program of Research. Manuel Martín Carrasco has received grants and served as a consultant, advisor or CME speaker for Angelini, Esteve, Idorsia, Janssen-Cilag, Lundbeck, Novartis, Pfizer, Rovi, the Ministry of Science (Carlos III Institute), and the Navarra Government. Víctor Pérez Sola has received grants and/or served as a consultant, advisor or speaker for AB-Biotics, AstraZeneca, Bristol-Myers-Squibb, Johnson & Johnson, Lundbeck, Medtronic, Otsuka, and Servier. Pilar Alejandra Sáiz has received grants and/or served as a consultant, advisor or speaker for Adamed, Alter Medica, Angelini Pharma, CIBERSAM, Ethypharm Digital Therapy, European Commission, Government of the Principality of Asturias, Instituto de Salud Carlos III, Johnson & Johnson, Lundbeck, Otsuka, Pfizer, Plan Nacional Sobre Drogas and Servier. Eduard Vieta has received grants and/or served as a consultant, advisor or speaker for AB-Biotics, AbbVie, Adamed, Angelini Pharma, Biogen, Beckley-Psytech, Biohaven, Boehringer-Ingelheim, Celon Pharma, Compass, Dainippon Sumitomo Pharma, Ethypharm, Ferrer, Gedeon Richter, GH Research, GlaxoSmithKline, HMNC, Idorsia, Johnson & Johnson, Lundbeck, Luye Pharma, Medincell, Merck, Neuraxpharm, Newron, Novartis, Orion Corporation, Organon, Otsuka, Roche, Rovi, Sage, Sanofi-Aventis, Sunovion, Takeda, Teva, and Viatris. Marta Torrens has received grants and/or served as a consultant, advisor or speaker for Adamet, Angelini Pharma, Camurus, Lundbeck, Otzuka, and Servier. Celso Arango has received grants and/or served as a consultant, advisor or speaker for Acadia, Ambrosetti S.p.A, Angelini, Bristol-Myers Squibb, Comunidad de Madrid, Fundación Alicia Koplowitz, Fundación Familia Alonso, Fundación Mutua Madrileña, Instituto de Salud Carlos III, Janssen-Cilag, Lundbeck, Ministerio Educación, Otsuka, Rovi, Stanley Foundation, Sunovion, Teva, and Takeda. Benedicto Crespo-Facorro has received grants and/or served as a consultant, advisor or speaker for Angelini, Johnson & Johnson, Lundbeck, Otsuka, and Rovi.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.